X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
ALEMBIC LTD Fact Sheet, ALEMBIC LTD Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC LTD Fact Sheet   (ALMC)

Here is the latest financial fact sheet of ALEMBIC LTD. For more details, see the ALEMBIC LTD quarterly results and ALEMBIC LTD share price and chart. For a sector overview, read our pharmaceuticals sector report.

ALEMBIC LTD Price History

Price Rs 36.9
Mkt Cap Rs m 20,408
Vol '000 26.4
P/E X 48.9
P/CF X 44.8
EPS (TTM) Rs 0.8
% ch % 1.7
No. of shares m 553.80
% ch week % -6.5
% ch 1-mth % -14.5
% ch 12-mth % -8.0
52 week H/L Rs 72.0/33.9
(As on Jul 20, 2018 03:37:00 PM)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

ALEMBIC LTD Financials

No. of Mths
Year Ending
12
Mar-14
12
Mar-15
*
12
Mar-16
*
12
Mar-17
*
12
Mar-18
*
5-Yr Chart
Click to enlarge
ALEMBIC LTD EQUITY SHARE DATA
High Rs1870534672 
Low Rs716293234 
Sales per share (Unadj.) Rs5.85.44.75.34.7 
Earnings per share (Unadj.) Rs1.14.08.85.46.1 
Diluted earnings per shareRs0.51.94.22.62.9 
Cash flow per share (Unadj.) Rs1.24.29.05.66.2 
Dividends per share (Unadj.) Rs0.150.150.150.200.20 
Adj. dividends per shareRs0.070.070.070.100.10 
Dividend yield (eoy) %1.20.30.40.50.4 
Book value per share (Unadj.) Rs8.619.827.734.140.7 
Adj. book value per shareRs4.29.513.416.519.6 
Shares outstanding (eoy) m267.03267.03267.03267.03267.03 
Bonus/Rights/Conversions  B1:1---- 
Price / Sales ratio x2.18.08.77.511.3 
Avg P/E ratio x11.210.84.77.28.7 
P/CF ratio (eoy) x10.410.24.67.08.5 
Price / Book Value ratio x1.42.21.51.21.3 
Dividend payout %13.63.81.73.73.3 
Avg Mkt Cap Rs m3,29811,46910,96210,52114,139 
No. of employees `000NANANANANA 
Total wages/salary Rs m273270238228207 
Avg. sales/employee Rs ThNMNMNMNMNM 
Avg. wages/employee Rs ThNMNMNMNMNM 
Avg. net profit/employee Rs ThNMNMNMNMNM 
ALEMBIC LTD INCOME DATA
Net Sales Rs m1,5361,4391,2601,4031,255 
Other income Rs m158208264310370 
Total revenues Rs m1,6941,6471,5241,7131,625 
Gross profit Rs m223958367111 
Depreciation Rs m2360615138 
Interest Rs m238022 
Profit before tax Rs m335235285324442 
Minority Interest Rs m00000 
Prior Period Items Rs m08252,0961,1791,212 
Extraordinary Inc (Exp) Rs m00-32-580 
Tax Rs m39-76-924 
Profit after tax Rs m2951,0662,3431,4541,630 
Gross profit margin %14.56.66.64.88.9 
Effective tax rate %11.8-2.92.1-2.65.4 
Net profit margin %19.274.1185.9103.6129.8 
ALEMBIC LTD BALANCE SHEET DATA
Current assets Rs m1,5431,6091,6891,9131,867 
Current liabilities Rs m907533486683591 
Net working cap to sales %41.474.895.487.6101.6 
Current ratio x1.73.03.52.83.2 
Inventory Days Days24821421713294 
Debtors Days Days66122815674 
Net fixed assets Rs m1,8001,7151,6241,7161,791 
Share capital Rs m534534534534534 
"Free" reserves Rs m8743,8395,9608,58010,324 
Net worth Rs m2,3075,2787,4049,11410,858 
Long term debt Rs m3313541041841 
Total assets Rs m3,5626,1928,0109,92411,591 
Interest coverage x15.429.3950.7203.8260.9 
Debt to equity ratio x0.10.1000 
Sales to assets ratio x0.40.20.20.10.1 
Return on assets %8.917.429.314.714.1 
Return on equity %12.820.231.616.015.0 
Return on capital %13.619.031.315.815.2 
Exports to sales %7.714.32.90.71.5 
Imports to sales %3.42.528.925.421.0 
Exports (fob) Rs m118205371019 
Imports (cif) Rs m5237364356263 
Fx inflow Rs m118205371019 
Fx outflow Rs m6342365357264 
Net fx Rs m55163-328-346-244 
ALEMBIC LTD CASH FLOW
From Operations Rs m -102 220 346 516 236 
From Investments Rs m 178 47 -48 -467 -224 
From Financial Activity Rs m -79 -250 -301 -50 -27 
Net Cashflow Rs m -3 17 -3 0 -15 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 64.0%
Foreign collaborators 0.0%
Indian inst/Mut Fund 0.2%
FIIs 9.7%
ADR/GDR 0.0%
Free float 26.1%
Shareholders 54,701
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF Alembic Road, Vadodara - 390 003
E-MAIL alembic.investors@alembic.co.in WEB www.alembiclimited.com
TELEPHONE (0265) 228 0550 FAX (0265) 228 2506
SECTOR PHARMACEUTICALS GROUP MISCELLANEOUS
TR AGENT Link Intime India, B-102-103, Shangrila Complex, 1st Flr., Akota, Vadodara-20
AUDITOR K. S. Aiyar & Co.
CHM: Chirayu R. Amin (MD) COMP SEC: Chirag K. Shukla YEAR OF INC: 1907 BSE CODE: 506235 FV (Rs): 2 DIV YIELD (%): 0.3

More Pharmaceuticals Company Fact Sheets:   LUPIN LTD  INDRAPRASTHA MEDICAL  DISHMAN PHARMA  PANACEA BIOTECH  INDOCO REMEDIES  

Compare ALEMBIC LTD With:   LUPIN LTD  INDRAPRASTHA MEDICAL  DISHMAN PHARMA  PANACEA BIOTECH  INDOCO REMEDIES  

Compare ALEMBIC LTD With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Day in Green; IT Stocks Lead Gains(Closing)

After opening the day in green, share markets in India witnessed positive trading activity throughout the day and ended the day in above the dotted line.

Views on news

ALEMBIC LTD Announces Quarterly Results (4QFY18); Net Profit Up 64.9% (Quarterly Result Update)

Jul 20, 2018 | Updated on Jul 20, 2018

For the quarter ended March 2018, ALEMBIC LTD has posted a net profit of Rs 46 m (up 64.9% YoY). Sales on the other hand came in at Rs 332 m (up 0.9% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

How to Avoid a 90% Loss Suffered by This Super Investor(The 5 Minute Wrapup)

Jul 12, 2018

Blindly following super investors is a dangerous game to play. Here's how you can avoid such mistakes.

The Answer to Your Wealth Worries: Small Caps (Especially Now)(Profit Hunter)

Jul 10, 2018

If you're worried about the markets - you are on the wrong track. This is opportunity - put your wealth-building hat on, instead - Richa shows you how...

The Multiple Problems with the Minimum Support Price (MSP) System(Vivek Kaul's Diary)

Jul 11, 2018

The price signals that MSP sends out, creates its own set of problems.

ICICI Pru Mutual Fund Tarakki Karega! - The Unethical Way?(Outside View)

Jul 11, 2018

PersonalFN explains how ICICI Prudential Mutual Fund flouted the norms of related party transactions while subscribing to the IPO of ICICI Securities.

PPF v/s Mutual Funds: Which Is Better?(Outside View)

Jul 10, 2018

PersonalFN highlights the key points of distinction between PPF and mutual funds.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK ALEMBIC LTD

  • Track your investment in ALEMBIC LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC LTD

ALEMBIC LTD - ASTRAZENECA PHARMA COMPARISON

COMPARE ALEMBIC LTD WITH

MARKET STATS